A narrative review of hydrogen therapy for COPD: aging-related insights.
Ya-Ting Chuang, Chun Tseng, Tao-An Chen · Open medicine (Warsaw, Poland) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined given the increasing burden of aging-related COPD and the emerging biological effects of molecular hydrogen, the researchers hypothesized that H₂ therapy may exert beneficial effects by modulating oxidative stress, inflammation, and aging pathways. Clinical findings demonstrated improved arterial blood gases, acid-base balance, and exercise tolerance in elderly COPD patients. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. Following Ferrari's narrative review framework, PubMed and Ovid MEDLINE were searched through October 2025 for clinical and preclinical studies examining H₂ interventions in COPD, chronic bronchitis, or emphysema, with emphasis on elderly populations or aging-related models.
What the Researchers Studied
The authors reviewed given the increasing burden of aging-related COPD and the emerging biological effects of molecular hydrogen, the researchers hypothesized that H₂ therapy may exert beneficial effects by modulating oxidative stress, inflammation, and aging pathways.
What Effects Did Molecular Hydrogen Have?
Following Ferrari's narrative review framework, PubMed and Ovid MEDLINE were searched through October 2025 for clinical and preclinical studies examining H₂ interventions in COPD, chronic bronchitis, or emphysema, with emphasis on elderly populations or aging-related models. Molecular hydrogen (H₂) exhibits selective antioxidant, anti-inflammatory, and anti-senescence properties that may provide therapeutic benefits for chronic obstructive pulmonary disease (COPD), particularly in aging populations where oxidative stress and chronic inflammation are prominent. Given the increasing burden of aging-related COPD and the emerging biological effects of molecular hydrogen, the researchers hypothesized that H₂ therapy may exert beneficial effects by modulating oxidative stress, inflammation, and aging pathways.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.